The new Crescina Transdermic Ri-Crescita PLC12 - Bulge-Stem consists of a double treatment
(contained in two different types of vials) which specifically promotes the physiological growth of hair
in the thinned out areas, separating the functions of the two complexes based on important and innovative components
active for re-growth. The two treatments have in common the formulation basis with the Re-growth complex
(Cysteine, Lysine and Glycoprotein) and the patent enhancers for transdermal technology.
PLC12 - The PLC12 treatment (Swiss Patent CH 713 030) contains the complex, in concentration
increased, of 12 Plate-Like molecules (sh-Polypeptide-11, sh-Polypeptide-1, sh-Polypeptide-3, sh-
Oligopeptide-2, sh-Polypeptide-31, sh-Polypeptide-9, sh-Oligopeptide-1, sh-Oligopeptide-4, sh-Polypeptide-
85, sh-Polypeptide-59, sh-Polypeptide-62 and sh-Polypeptide-4) which, being synthetic substances similar to
endogenous peptide molecules naturally present in the hair system, are responsible for promoting
physiologically and synergistically hair growth
BULGE-STEM - The Bulge-Stem treatment contains the formulation evolution of the HFSC complex (Patent
Swiss CH 703 390) consisting of Hydrolyzed Rice Protein and Eryobotrya Japonica, which is enriched with
Dihydroquercetin-Glucoside and Tripeptide-10 Citrulline: it is able to protect and keep whole
the environment of the bulge, inside the hair follicle, where the cells responsible for starting are stored
of the new life cycles of the hair.